Amyris Inc (AMRS)

3.04 -0.18 (-5.59%)
Close USD Disclaimer
3.01 -0.03 (-0.99%)

Amyris Inc Company Profile

Industry
Chemicals
Sector
Materials
Employees
980
Equity Type
ORD
Amyris, Inc. is a synthetic biotechnology company. The Company applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The Company's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The Company is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance. Its brands include Biofene, Hemisqualane, Biossance, clean beauty skincare, Pipette, clean baby skincare and Purecane.
Contact Information
Address
EmeryVille,94608 United States
Phone
510 450 0761
Fax
-
Top Executives
Name
Age
Since
Title
L. John Doerr 69 2006 Independent Director
Geoffrey M. Duyk 62 2012 Interim Independent Chair of the Board
John G. Melo 55 2007 President, CEO & Director
Patrick Y. Yang 73 2014 Independent Director
Steven R. Mills 65 2012 Independent Director
Lisa Qi 49 2019 Independent Director
Julie Spencer Washington 55 2020 Independent Director
Philip Eykerman 52 2017 Director
Frank F. C. Kung 72 2017 Independent Director
James Francis McCann 70 2019 Independent Director
Ana Dutra 58 2022 Independent Director
Ryan Panchadsaram 37 2021 Independent Director
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles